Rapid clinical progression to AIDS and death in a persistently seronegative HIV-1 infected heterosexual young man

AIDS

Volumn 23, Issue 17, 2009, Pages 2359-2362

  Bártolo, Inês ^a,b   Camacho, Ricardo ^c,d   Barroso, Helena ^a,b   Bezerra, Victor ^e   Taveira, Nuno ^a,b  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

^c Centro Hospitalar Lisboa Norte   (Portugal)

^d INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^e Hospital Distrital de Santarm   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INDINAVIR; VIRUS ANTIBODY; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; DEATH; DIARRHEA; DISEASE COURSE; EXTRAPULMONARY TUBERCULOSIS; FATIGUE; FEMALE; FEVER; GENETIC ANALYSIS; HETEROSEXUAL MALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MALE; NUCLEOTIDE SEQUENCE; OROPHARYNX CANDIDIASIS; PERIPHERAL NEUROPATHY; PHYLOGENY; PRIORITY JOURNAL; SEROCONVERSION; SEROLOGY; SEXUALITY; VIRUS LOAD; VIRUS STRAIN; WASTING SYNDROME; WEIGHT REDUCTION;

DISEASE PROGRESSION; FATAL OUTCOME; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; ODDS RATIO; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; YOUNG ADULT;

EID: 70449344717     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328332d5e1     Document Type: Article

References (15)

1. Cardoso AR, Goncalves C, Pascoalinho D, Gil C, Ferreira AF, Bartolo I, Taveira N. Seronegative infection and AIDS caused by an A2 subsubtype HIV-1. AIDS 2004; 18:1071-1074.
2. Baldrich-Rubio E, Anagonou S, Stirrups K, Lafia E, Candotti D, Lee H, Allain JP. A complex human immunodeficiency virus type 1A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa. J Gen Virol 2001; 82:1095-1106.
3. Candotti D, Adu-Sarkodie Y, Davies F, Baldrich-Rubio E, Stirrups K, Lee H, Allain JP. AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection. J Med Virol 2000; 62:1-8.
4. Simon F, Mauclere P, Roques P, Loussert-Ajaka I, Muller-Trutwin MC, Saragosti S, et al. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998; 4:1032-1037. (Pubitemid 28417335)
5. Bartolo I, Casanovas J, Bastos R, Rocha C, Abecasis AB, Folgosa E, et al. HIV-1 genetic diversity and transmitted drug resistance in healthcare settings in Maputo, Mozambique. J Acquir Immune Defic Syndr 2009; 51:323-331.
6. Sandhu GS, Kline BC, Stockman L, Roberts GD. Molecular probes for diagnosis of fungal infections. J Clin Microbiol 1995; 33:2913-2919.
7. Thomson MM, Delgado E, Manjon N, Ocampo A, Villahermosa ML, Marino A, et al. HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users. AIDS 2001; 15:509-516.
8. Esteves A, Parreira R, Piedade J, Venenno T, Franco M, Germano de Sousa J, et al. Spreading of HIV-1 subtype G and envB/gagG recombinant strains among injecting drug users in Lisbon, Portugal. AIDS Res Hum Retroviruses 2003; 19:511-517.
9. Sing T, Low AJ, Beerenwinkel N, Sander O, Cheung PK, Domingues FS, et al. Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antivir Ther 2007; 12:1097-1106.
10. Saksena NK, Wang B, Dyer WB. Biological and molecular mechanisms in progression and nonprogression of HIV disease. AIDS Rev 2001; 3:133-144.
11. Richman DD, Wrin T, Little SJ, Petropoulos CJ. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA 2003; 100:4144-4149.
12. Sullivan PS, Schable C, Koch W, Do AN, Spira T, Lansky A, et al. Persistently negative HIV-1 antibody enzyme immunoassay screening results for patients with HIV-1 infection and AIDS: serologic, clinical, and virologic results. Seronegative AIDS Clinical Study Group. AIDS 1999; 13:89-96.
13. Cho YK, Sung H, Bae IG, Oh HB, Kim NJ, Woo JH, Kim YB. Full sequence of HIV type 1 Korean subtype B in an AIDS case with atypical seroconversion: TAAAA at TATA box. AIDS Res Hum Retroviruses 2005; 21:961-964.
14. DalmauJ, Puertas MC, Azuara M,Marino A, Frahm N,Mothe B, et al. Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection. Clin Infect Dis 2009; 48:229-238.
15. Jurriaans S, Sankatsing SU, Prins JM, Schuitemaker H, Lange J, Van Der Kuyl AC, Cornelissen M. HIV-1 seroreversion in an HIV-1-seropositive patient treated during acute infection with highly active antiretroviral therapy and mycophenolate mofe-til. AIDS 2004; 18:1607-1608